Table 4.
Known group validity of SCNS-26 tool in Hawassa comprehensive Specialized Hospital, Hawassa, Ethiopia, 2019
| Variable | Physiological needs | Health system information needs | Physical & daily living needs | Patient care & support needs | Sexuality needs | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean rank | P-value | Mean rank | P-value | Mean rank | P-value | Mean rank | P-value | Mean rank | P-value | |
| Sociodemographic characteristics | ||||||||||
| Age | 0.517 | 0.557 | 0.441 | 0.232 | 0.022 Ҩ | |||||
| 18–64 | 86.31 | 86.24 | 86.46 | 87.00 | 87.90 | |||||
| ≥ 65 | 78.18 | 78.88 | 76.85 | 72.03 | 63.91 | |||||
| Sex | 0.899 | 0.498 | 0.958 | 0.291 | 0.692 | |||||
| Male | 86.26 | 81.45 | 85.19 | 79.18 | 83.52 | |||||
| Female | 85.20 | 87.09 | 85.62 | 87.99 | 86.28 | |||||
| Clinical characteristics | ||||||||||
| Comorbidity | 0.380 | 0.370 | 0.976 | 0.877 | 0.911 | |||||
| Yes | 78.76 | 78.65 | 85.27 | 84.32 | 86.21 | |||||
| No | 87.12 | 87.15 | 85.55 | 85.78 | 85.33 | |||||
| Type of treatment | 0.017 Ҩ | 0.003 Ҩ | 0.302 | 0.0001 Ҩ | 0.009 Ҩ | |||||
| Chemotherapy/radiotherapy | 90.55 | 91.71 | 87.68 | 94.27 | 90.12 | |||||
| Hormonal/surgery | 69.60 | 65.95 | 78.65 | 57.90 | 70.95 | |||||
| Stage of cancer | 0.386 | 0.268 | 0.537 | 0.759 | 0.194 | |||||
| Early stage (I-II) | 90.04 | 91.28 | 82.28 | 87.10 | 79.84 | |||||
| Late stage (III-IV) | 83.15 | 82.51 | 87.17 | 84.67 | 88.43 | |||||
Ҩ statistically significant at p-value < 0.05